our Human Resources policy

RESOURCES

Circle Oncodesign Services

The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.

Filter by category
  • All
  • Blog
  • Congress
  • Scientific resource
  • Webinar
  • Poster
  • Scientific publication
  • Press release
  • Press coverage
  • News
Filter by category
Circle Oncodesign Services
Congress
21/02/2023

Oncodesign Services Events in March 2023

Oncodesign is taking part in many events this March. Here is a short selection of where we are travelling over the next few weeks. Learn more here

10/02/2023

The International Day of Women and Girls in Science

We met with women employees of Oncodesign Services to talk their careers and their ambitions for a better valorization of women in Science. Learn more here

Blog
02/02/2023

Why do preclinical cancer models still fail in the clinic?

We at Oncodesign Services strive to develop alternative Preclinical Cancer Models to better suit your drug development. Read more about our solutions here.

News
19/01/2023

Oncodesign S.A. is now Oncodesign Services S.A.

Oncodesign Services is chane announced the change of name to Oncodesign Services and a new COMEX for 2023.

Scientific publication
16/01/2023

Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer

Liposomal Irinotecan is hypothesized to have a higher therapeutic index than its non-liposomal counterpart in mice with Pancreatic Cancer. Read more here.

Oncodesign Services - Dijon
News
14/12/2022

Oncodesign Services looks to the future

As Oncodesign evolves into Oncodesign Services and begins its journey as an independent business, CEO Fabrice Viviani explains his hopes and plans for the company’s future

Scientific publications | Oncodesign Services
Scientific publication
25/11/2022

Calcium(II)-Catalyzed Chemoselective and Regioselective Epoxide Ring-Opening with NH Sulfoximines

In this paper we describe methods for the Organic Synthesis of 1,2-sulfoximidoyl ethanols thanks to an Epoxide Ring Opening with NH Sulfoximines. Read more.

Gut microbes - Microbiome
Blog
08/11/2022

Why studying the gut microbes could help to cure?

We explore the importance of Gut Microbes on our health by discussing five of those Gut-Organ Axis - brain, intestine, liver, lung, and skin. Read more here.

Scientific publications | Oncodesign Services
Scientific publication
03/11/2022

Intranasal delivery of a chimpanzee adenovirus vector expressing a pre-fusion spike (BV-AdCoV-1) protects golden Syrian hamsters against SARS-CoV-2 infection

We investigated the efficiency of Vaccine Vector based on Chimpanzee Adenovirus in golden Syrian hamsters against SARS-Cov-2 infection. Learn more here.

Poster
01/11/2022

Translational pharmacology supporting biologics development in Oncology

Translational Pharmacology is responsible for connecting products of novel molecular research, such as Biologics, to the patients that need it. Learn more here.

Financial Press Release | Oncodesign
Press release
19/10/2022

ERES IV acquires a majority stake in Oncodesign Services

ERES IV, advised by Elyan Partners, acquires a majority stake in Oncodesign Services and will file an offer on the company’s remaining shares. Find out more

Webinar
13/10/2022

Fragment-Based Drug Discovery — Hitting Targets Using the Right Chemistry and Expertise Alliances

Learn about Fragment-Based Drug Discovery (FBDD) and its Applications in our Webinar with leading experts from the field of FBDD.